NYSE · RADLY
Healthcare · Medical - Pharmaceuticals
$3.71
Down-$0.15 (-3.89%)
Updated Aug 26, 2026, 6:47 PM
SID Score
4.7/10
Composite research score
Smart Money
46/100
Neutral
Price performance
1M range · 0 trading sessions · Daily adjusted prices
RADLY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning RADLY.
RADLY research
Company profile and research snapshot.
RAIA DROGASIL SA SPNS/ADR
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Aug 7, 2026
Raia Drogasil SA (RADLY) delivers 18.3% revenue growth and expands market share by 170 bps, while navigating GLP-1 price dynamics and improving financial leverage.
SeekingAlpha · Aug 5, 2026
Raia Drogasil S.A. (RADLY) Q2 2026 Earnings Call August 5, 2026 9:00 AM EDTCompany ParticipantsRenato Raduan - CEO & Member of Executive BoardFlavio de...
SeekingAlpha · Aug 5, 2026
2026-08-05. The following slide deck was published by Raia Drogasil S.A.
SeekingAlpha · Mar 6, 2026
Raia Drogasil S.A. (RADLY) Q4 2025 Earnings Call March 4, 2026 8:00 AM ESTCompany ParticipantsRenato Raduan - CEO & Member of Executive BoardFlavio de...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning RADLY.
